Is severe leathery-type eczema common in patients undergoing chronic hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severe Leathery Eczema in Dialysis Patients

Severe leathery-type eczema is not a common or characteristic finding in dialysis patients—instead, dry skin (xerosis) and pruritus are the predominant cutaneous manifestations.

What Actually Occurs in Dialysis Patients

The skin changes in chronic hemodialysis patients follow a distinct pattern that differs from classic eczematous presentations:

Most Common Cutaneous Findings

Xerosis (dry skin) is the most common cutaneous sign in dialysis patients, occurring in 69-79% of patients 1, 2, 3. This is not the same as leathery eczema—it presents as generalized dryness without the lichenified, thickened appearance typical of chronic eczematous conditions.

Pruritus affects 42-56% of hemodialysis patients 1, 2, 3, and while chronic scratching can lead to excoriated skin, this typically manifests as:

  • Excoriations and scratch marks
  • Hyperpigmentation in affected areas
  • Prurigo nodularis-like lesions in some cases

Other Dermatologic Manifestations

The actual spectrum of skin findings in dialysis patients includes 2, 3, 4:

  • Ecchymosis and purpura (60-66%)
  • Pigmentary changes, primarily hyperpigmentation (17-43%)
  • Follicular hyperkeratosis (15%)
  • Kyrle's disease (perforating follicular dermatosis) in 6.9-21%
  • Various infections (fungal 27-30%, bacterial 13-15%, viral 11-12%)

Why Leathery Eczema Is Not Characteristic

True eczematous dermatitis is actually uncommon in dialysis patients, occurring in only 2-4.8% of cases 3, 4. When eczema does occur around the arteriovenous fistula site (11.5% of patients), it is typically due to contact dermatitis from locally-applied products rather than a systemic manifestation of uremia 4.

The pathophysiology in dialysis patients centers on:

  • Uremic toxin accumulation
  • Calcium-phosphate metabolic disorders 5
  • Altered skin barrier function leading to xerosis
  • Neuropathic mechanisms causing pruritus

These mechanisms do not typically produce the lichenified, leathery skin texture seen in chronic atopic dermatitis or chronic eczema from repeated scratching.

Clinical Pitfall

Do not confuse severe xerosis with eczema. While both can present with dry, scaly skin, xerosis lacks the inflammatory component, weeping, and lichenification characteristic of eczema. The management differs significantly—xerosis requires aggressive emollient therapy 1, while true eczema would require anti-inflammatory treatment.

If a dialysis patient presents with what appears to be severe leathery eczema, consider:

  • Concurrent atopic dermatitis or other primary dermatologic condition unrelated to dialysis
  • Contact dermatitis from dialysis-related products
  • Secondary changes from chronic scratching due to uremic pruritus
  • Alternative diagnoses such as acquired perforating dermatosis

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.